Britain Manchester Coronavirus reports testing vaccine Britain Manchester

Oxford coronavirus vaccine trial resumes after pause when UK participant became ill

Reading now: 590
manchestereveningnews.co.uk

coronavirus vaccine is to resume after a short pause when a participant in the UK became unwell.The university announced on Saturday that the trial was to resume and that "some 18,000 individuals" globally had received study vaccines as part of the trial.The vaccine is being developed by AstraZeneca and Oxford University and was only halted on Tuesday night as a result of a reported side-effect in a participant in the UK.AstraZeneca issued a statement on Tuesday night saying the late-stage studies of the vaccine had been paused while the company investigated whether the patient’s reported side effect is connected with the vaccine.Get the latest updates from across Greater Manchester direct to your inbox with the free MEN newsletterYou can.

Read more on manchestereveningnews.co.uk
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA